Indonesia speeds up new TB vaccine development to combat rising cases
Indonesia is developing a new Tuberculosis (TB) vaccine to strengthen the fight against TB, which has claimed an average of 150,000 lives annually.
Indonesia is developing a new Tuberculosis (TB) vaccine to strengthen the fight against TB, which has claimed an average of 150,000 lives annually.
The landmark trial will evaluate the efficacy of India’s indigenous tetravalent dengue vaccine, DengiAll, developed by Panacea Biotec.
Specifically, the team compared the immune responses in people who were protected against CMV infection after receiving the older vaccine.
For years, the human papillomavirus (HPV) vaccine has been widely recognized as a crucial weapon against cervical cancer in women.
India’s billionaire "vaccine prince" Adar Poonawalla has reached a deal for London’s most expensive home sale of the year, agreeing to pay about 138 mn pound for a 25,000 square foot Mayfair mansion, media reports said.
“We administered 147 vaccines on Monday, a marginal 12 per cent increase over yesterday. Encouragingly, there has been a 20 per cent rise in number of precaution doses in the 18-59 category. The numbers should further increase as the news spreads about the booster in this age group,”
Approximately 35 per cent of the world’s population has not received at least one dose, while more than 42 per cent of the world’s population has not been fully vaccinated. One can easily observe the inequitable distribution of vaccines between the Global North and the Global South.
The statement further said that Covovax is the fourth vaccine to receive EUA from the DCGI for use among adolescents 12 and older.
The highest uptake has been among the frontline workers, with over 77,000 persons having received the third dose.
Quoting some media reports alleging vaccine shortage in Maharashtra, the ministry stated that such reports are incorrect.
